Google’s informal corporate slogan is “Don’t be evil.” Whole Foods is a Fortune 500 company with a net revenue of 10 billion dollar that prides itself on a commitment to social responsibility. Both companies have pledged to do long-term good in the world, even at the expense of short-term gains, and both are wildly successful.
If corporations can be profitable as a result of their commitments to social justice and corporate ethics, why can’t this doctrine be extended to the pharmaceutical industry? Someday, a company called GoodPharma might reach the Fortune 500 on the basis of a pledge to improve access to medicine, conduct international research trials in accordance with the highest standards of research ethics, engage in research on orphan diseases, publish negative research findings, promptly report information about adverse effects, and generally act as a model for ethical industry practices. If this business model hasn’t been explored, it should be.
Continue reading “Google, Whole Foods, and … Big Pharma?”
Filed Under: OP-ED
Tagged: Access to Medicine Index, Big pharma, Bill of Health, Corporate Social Responsibility, Ethical Practices, GlaxoSmithKline, GoodPharma, Google, Harvard Law School, Nadia Sawicki, Petrie-Flom Center, Pharma, Physicians, Public Access, Whole Foods
Dec 10, 2012
Next Tuesday, those of us registered in Massachusetts will have the opportunity to vote on “Question 2″ – prescribing medication to end life, otherwise known as physician-assisted suicide.
As described by the state secretary, “This proposed law would allow a physician licensed in Massachusetts to prescribe medication, at a terminally ill patient’s request, to end that patient’s life. To qualify, a patient would have to be an adult resident who (1) is medically determined to be mentally capable of making and communicating health care decisions; (2) has been diagnosed by attending and consulting physicians as having an incurable, irreversible disease that will, within reasonable medical judgment, cause death within six months; and (3) voluntarily expresses a wish to die and has made an informed decision.”
There are, of course, a number of other safeguards built in, such as the need to make the request twice, separated by 15 days, in the presence of witnesses. However, there could probably be stronger safeguards to protect individuals who are experiencing depression and anxiety, and might have preferable alternatives to physician-assisted death.
Continue reading “Physician Assisted Suicide in Massachusetts”
Filed Under: THCB
Tagged: Bill of Health, End of Life Care, Harvard Law School, Holly Fernandez Lynch, Massachusetts, Massachusetts Question 2, Oregon, PAS, Petrie-Flom Center, Physician-Assisted Suicide, Washington state
Nov 4, 2012